Age and sex related differences in subcortical brain iron concentrations among healthy adults

NeuroImage

Volumn 122, Issue , 2015, Pages 385-398

  Persson, Ninni ^a,b,c   Wu, Jianlin ^e,f   Zhang, Qing ^e   Liu, Ting ^e   Shen, Jing ^e   Bao, Ruyi ^e   Ni, Mingfei ^e   Liu, Tian ^c   Wang, Yi ^c,d   Spincemaille, Pascal ^c  

^a STOCKHOLM UNIVERSITY   (Sweden)

^b Stockholm Brain Institute   (Sweden)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

^d School of Operations Research and Industrial Engineering   (United States)

^e DALIAN MEDICAL UNIVERSITY   (China)

^f DALIAN UNIVERSITY   (China)

Author keywords

Brain aging; Gender differences; Iron; Quantitative susceptibility mapping; Sex differences; Sub cortical nuclei

Indexed keywords

IRON;

ADULT; AGE; AGED; ANATOMICAL VARIATION; ARTICLE; BIOACCUMULATION; BRAIN LEVEL; BRAIN MAPPING; CAUDATE NUCLEUS; CONTROLLED STUDY; DENTATE NUCLEUS; FEMALE; GLOBUS PALLIDUS; GRAY MATTER; HISTOLOGY; HUMAN; IN VIVO STUDY; MALE; NEUROANATOMY; NEUROIMAGING; POSTMENOPAUSE; PRIORITY JOURNAL; PULVINAR; PUTAMEN; QUANTITATIVE SUSCEPTIBILITY MAPPING; RED NUCLEUS; SEX DIFFERENCE; SUBCORTEX; SUBSTANTIA NIGRA; THALAMUS; BRAIN; CEREBELLUM NUCLEUS; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; BRAIN; CEREBELLAR NUCLEI; FEMALE; GLOBUS PALLIDUS; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULVINAR; PUTAMEN; RED NUCLEUS; SEX FACTORS; SUBSTANTIA NIGRA; YOUNG ADULT;

EID: 84940704527     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2015.07.050     Document Type: Article

References (98)

1. Acosta-Cabronero J., Williams G.B., Cardenas-Blanco A., Arnold R.J., Lupson V., Nestor P.J. In vivo quantitative susceptibility mapping (QSM) in Alzheimer's disease. PLoS ONE 2013, 8(11).
2. Al-Azzawi F., Palacios S. Hormonal changes during menopause. Maturitas 2009, 63(2):135-137.
3. Andersen H.H., Johnsen K.B., Moos T. Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration. Cell. Mol. Life Sci. 2014, 71(9):1607-1622.
4. Aquino D., Bizzi A., Grisoli M., Garavaglia B., Bruzzone M.G., Nardocci N., . . ., Chiapparini L. Age-related iron deposition in the basal ganglia: quantitative analysis in healthy subjects. Radiology 2009, 252(1):165-172.
5. Barkai A.I., Durkin M., Dwork A.J., Nelson H.D. Autoradiographic study of iron-binding sites in the rat brain: distribution and relationship to aging. J. Neurosci. Res. 1991, 29(3):390-395.
6. Bartzokis G., Aravagiri M., Oldendorf W.H., Mintz J., Marder S.R. Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores. Magn. Reson. Med. 1993, 29(4):459-464.
7. Bartzokis G., Beckson M., Hance D.B., Marx P., Foster J.A., Marder S.R. MR evaluation of age-related increase of brain iron in young adult and older normal males. Magn. Reson. Imaging 1997, 15(1):29-35.
8. Bartzokis G., Tishler T.A., Shin I.S., Lu P.H., Cummings J.L. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. N. Y. Acad. Sci. 2004, 224-236.
9. Bartzokis G., Tishler T.A., Lu P.H., Villablanca P., Altshuler L.L., Carter M., . . ., Mintz J. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging 2007, 28(3):414-423.
10. Bartzokis G., Lu P.H., Tingus K., Peters D.G., Amar C.P., Tishler T.A., . . ., Connor J.R. Gender and iron genes may modify associations between brain iron and memory in healthy aging. Neuropsychopharmacology 2011, 36(7):1375-1384.
11. Benes F.M. Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch. Gen. Psychiatry 1994, 51(6):477.
12. Bentler P.M., Bonett D.G. Significance tests and goodness of fit in the analysis of covariance structures. Psychol. Bull. 1980, 88:588-606.
13. Berg D., Youdim M.B. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 2006, 17(1):5-17.
14. Bilgic B., Pfefferbaum A., Rohlfing T., Sullivan E.V., Adalsteinsson E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. NeuroImage 2012, 59(3):2625-2635.
15. Brown R.W., Norman Y.-C., Haacke E.M., Thompson M.R., Venkatesan R. Magnetic Resonance Imaging: Physical Principles and Sequence Design 2014, John Wiley & Sons.
16. Browne M.W., Cudeck R. Alternative ways of assessing model fit. Testing Structural Equation Models 1993, 136-162. Sage, Beverly Hills, CA. K.A. Bollen, J.S. Long (Eds.).
17. Browne M.W., MacCallum R.C., Kim C.-T., Andersen B.L., Glaser R. When fit indices and residuals are incompatible. Psychol. Methods 2002, 7(4):403-421.
18. Chen T.Y., Tsai K.L., Lee T.Y., Chiueh C.C., Lee W.S., Hsu C. Sex-specific role of thioredoxin in neuroprotection against iron-induced brain injury conferred by estradiol. Stroke 2010, 41(1):160-165.
19. Cherubini A., Peran P., Caltagirone C., Sabatini U., Spalletta G. Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. NeuroImage 2009, 48(1):29-36.
20. Cheung E., Tsang S., Bow C., Soong C., Yeung S., Loong C., . . ., Kung A. Bone loss during menopausal transition among southern Chinese women. Maturitas 2011, 69(1):50-56.
21. Cohen J. A power primer. Psychol. Bull. 1992, 112(1):155-159.
22. de Rijk M.C., Launer L.J., Berger K., Breteler M.M., Dartigues J.F., Baldereschi M., . . ., Hofman A. Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 2000, 54(11 Suppl 5):S21-23.
23. de Rochefort L., Liu T., Kressler B., Liu J., Spincemaille P., Lebon V., . . ., Wang Y. Quantitative susceptibility map reconstruction from MR phase data using Bayesian regularization: validation and application to brain imaging. Magn. Reson. Med. 2010, 63(1):194-206.
24. Deh K., Nguyen T.D., Eskreis-Winkler S., Prince M.R., Spincemaille P., Gauthier S., . . ., Wang Y. Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors. J. Magn. Reson. Imaging 2015, [Epub ahead of print]. 10.1002/jmri.24943.
25. Dixon S.J., Stockwell B.R. The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 2014, 10(1):9-17.
26. Dong J., Liu T., Chen F., Zhou D., Dimov A., Raj A., . . ., Wang Y. Simultaneous phase unwrapping and removal of chemical shift (SPURS) using graph cuts: application in quantitative susceptibility mapping. IEEE Trans. Med. Imaging 2015, 34(2):531-540.
27. Dunn O.J. Multiple comparisons among means. J. Am. Stat. Assoc. 1961, 56(293):52-64.
28. Dwork A.J., Lawler G., Zybert P.A., Durkin M., Osman M., Willson N., Barkai A.I. An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res. 1990, 518(1-2):31-39.
29. Fjell A.M., Walhovd K.B. Structural brain changes in aging: courses, causes and cognitive consequences. Rev. Neurosci. 2010, 21(3):187-221.
30. Fleming D.J., Jacques P.F., Massaro J.M., D'Agostino R.B., Wilson P.W., Wood R.J. Aspirin intake and the use of serum ferritin as a measure of iron status. Am. J. Clin. Nutr. 2001, 74(2):219-226.
31. Floyd R.A., Carney J.M. The role of metal ions in oxidative processes and aging. Toxicol. Ind. Health 1993, 9(1-2):197-214.
32. Fornage M., Chiang Y.A., O'Meara E.S., Psaty B.M., Reiner A.P., Siscovick D.S., . . ., Longstreth W.T. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: the Cardiovascular Health Study. Stroke 2008, 39(7):1952-1959.
33. Franceschi C., Bonafe M., Valensin S., Olivieri F., De Luca M., Ottaviani E., De Benedictis G. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 2000, 908:244-254.
34. Gelman B.B. Iron in CNS disease. J. Neuropathol. Exp. Neurol. 1995, 54(4):477-486.
35. Gold E.B., Bromberger J., Crawford S., Samuels S., Greendale G.A., Harlow S.D., Skurnick J. Factors associated with age at natural menopause in a multiethnic sample of midlife women. Am. J. Epidemiol. 2001, 153(9):865-874.
36. Gorell J.M., Ordidge R.J., Brown G.G., Deniau J.C., Buderer N.M., Helpern J.A. Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease. Neurology 1995, 45(6):1138-1143.
37. Gregorich S.E. Do self-report instruments allow meaningful comparisons across diverse population groups? Testing measurement invariance using the confirmatory factor analysis framework. Med. Care 2006, 44(11 Suppl 3):S78-S94.
38. Gu Y., Xi G., Liu W., Keep R.F., Hua Y. Estrogen reduces iron-mediated brain edema and neuronal death. Acta Neurochir. Suppl. 2010, 106:159-162.
39. Haacke E.M., Xu Y., Cheng Y.C., Reichenbach J.R. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 2004, (52):612-618.
40. Haacke E.M., Cheng N.Y., House M.J., Liu Q., Neelavalli J., Ogg R.J., . . ., Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005, 23(1):1-25.
41. Haacke E.M., Ayaz M., Khan A., Manova E.S., Krishnamurthy B., Gollapalli L., . . ., Kirsch W. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J. Magn. Reson. Imaging 2007, 26(2):256-264.
42. Haacke E.M., Miao Y., Liu M., Habib C.A., Katkuri Y., Liu T., Wu J. Correlation of putative iron content as represented by changes in R2* and phase with age in deep gray matter of healthy adults. J. Magn. Reson. Imaging 2010, 32(3):561-576.
43. Hagemeier J., Dwyer M.G., Bergsland N., Schweser F., Magnano C.R., Heininen-Brown M., . . ., Zivadinov R. Effect of age on MRI phase behavior in the subcortical deep gray matter of healthy individuals. AJNR Am. J. Neuroradiol. 2013, 34(11):2144-2151.
44. Hallgren B., Sourander P. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 1958, 3(1):41-51.
45. Hu L.-t, Bentler P.M. Fit indices in covariance structure modeling: sensitivity to underparameterized model misspecification. Psychol. Methods 1998, 3(4):424.
46. Hu L.t., Bentler P.M. Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equ. Model. Multidiscip. J. 1999, 6(1):1-55.
47. Jensen J.H., Szulc K., Hu C., Ramani A., Lu H., Xuan L., . . ., Schenck J. Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain. Magn. Reson. Med. 2009, 61(2):481-485.
48. Jöreskog K.G. A general method for analysis of covariance structures. Biometrika 1970, 57(2):239-251.
49. Kell D.B. Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med. Genet. 2009, 2(1):2.
50. Klohs J., Politano I.W., Deistung A., Grandjean J., Drewek A., Dominietto M., . . ., Rudin M. Longitudinal assessment of amyloid pathology in transgenic arcAbeta mice using multi-parametric magnetic resonance imaging. PLoS One 2013, 8:e66097.
51. Langkammer C., Schweser F., Krebs N., Deistung A., Goessler W., Scheurer E., . . ., Fazekas F. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. NeuroImage 2012, 62(3).
52. Langkammer C., Ropele S., Pirpamer L., Fazekas F., Schmidt R. MRI for iron mapping in Alzheimer's disease. Neurodegener. Dis. 2013, 13(2-3):189-191.
53. Li J., Chang S., Liu T., Wang Q., Cui D., Chen X., . . ., Wisnieff C. Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping. Magn. Reson. Med. 2012, 68(5):1563-1569.
54. Li L., Leigh J.S. Quantifying arbitrary magnetic susceptibility distributions with MR. Magn. Reson. Med. 2004, 51(5):1077-1082. 10.1002/mrm.20054.
55. Li W., Wu B., Batrachenko A., Bancroft-Wu V., Morey R.A., Shashi V., . . ., Liu C. Differential developmental trajectories of magnetic susceptibility in human brain gray and white matter over the lifespan. Hum. Brain Mapp. 2014, 35(6):2698-2713.
56. Lin P.-Y., Chao T.-C., Wu M.-L. Quantitative susceptibility mapping of human brain at 3T: a multisite reproducibility study. AJNR Am. J. Neuroradiol. 2014, (Epub ahead of print). 10.3174/ajnr.A4137.
57. Liu T., D.Liu T., de Rochefort L., LeDoux J., Zhang Q., Prince M.R., Wu J., Wang Y. Measurement of iron concentration in human brain using quantitative susceptibility mapping (QSM): correlation with age. Proc. Int. Soc. Magn. Reson. Med. 2010, 18.
58. Liu T., Surapaneni K., Lou M., Cheng L., Spincemaille P., Wang Y. Cerebral microbleeds: burden assessment by using quantitative susceptibility mapping. Radiology 2012, 262(1):269-278.
59. Liu T., Xu W., Spincemaille P., Avestimehr A.S., Wang Y. Accuracy of the morphology enabled dipole inversion (MEDI) algorithm for quantitative susceptibility mapping in MRI. IEEE Trans. Med. Imaging 2012, 31(3):816-824.
60. Liu T., D.Zhou D., Spincemaille P., Wang Y. Differential approach to quantitative susceptibility mapping without background field removal. Proc. 22nd Annu. Meet. ISMRM, Milan, Italy 2014, 0597.
61. Lundberg V., Tolonen H., Stegmayr B., Kuulasmaa K., Asplund K. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. Maturitas 2004, 48(1):39-49.
62. Maschke M., Weber J., Dimitrova A., Bonnet U., Bohrenkämper J., Sturm S., . . ., Diener H.-C. Age-related changes of the dentate nuclei in normal adults as revealed by 3D fast low angle shot (FLASH) echo sequence magnetic resonance imaging. J. Neurol. 2004, 251(6):740-746.
63. McArdle J.J. Current directions in structural factor analysis. Curr. Dir. Psychol. Sci. 1996, 11-18.
64. Meredith W., Teresi J.A. An essay on measurement and factorial invariance. Med. Care 2006, 44(11):S69-S77.
65. Mills E., Dong X.-p., Wang F., Xu H. Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders. Futur. Med. Chem. 2010, 2(1):51-64.
66. Mitrofanis J., Guillery R.W. New views of the thalamic reticular nucleus in the adult and the developing brain. Trends Neurosci. 1993, 16:240-245.
67. Morris C., Candy J., Oakley A., Bloxham C., Edwardson J. Histochemical distribution of non-haem iron in the human brain. Cells Tissues Organs 1992, 144(3):235-257.
68. Peran P., Cherubini A., Luccichenti G., Hagberg G., Démonet J.F., Rascol O., . . ., Sabatini U. Volume and iron content in basal ganglia and thalamus. Hum. Brain Mapp. 2009, 30(8):2667-2675.
69. Persson N., Lavebratt C., Wahlin A. Synergy effects of HbA1c and variants of APOE and BDNFVal66Met explains individual differences in memory performance. Neurobiol. Learn. Mem. 2013, 106:274-282.
70. Persson N., Ghisletta P., Dahle C.L., Bender A.R., Yang Y., Yuan P., . . ., Raz N. Regional brain shrinkage over two years: individual differences and effects of pro-inflammatory genetic polymorphisms. NeuroImage 2014, 28:334-348.
71. Pfefferbaum A., Adalsteinsson E., Rohlfing T., Sullivan E.V. MRI estimates of brain iron concentration in normal aging: comparison of field-dependent (FDRI) and phase (SWI) methods. NeuroImage 2009, 47(2):493-500.
72. Piñero D.J., Connor J.R. Iron in the brain: an important contributor in normal and diseased states. Neuroscientist 2000, 6(6):435-453.
73. Quintana C., Bellefqih S., Laval J.Y., Guerquin-Kern J.L., Wu T.D., Avila J., . . ., Patiño C. Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. J. Struct. Biol. 2006, 153(1):42-54.
74. Ramos P., Santos A., Pinto N.R., Mendes R., Magalhães T., Almeida A. Iron levels in the human brain: a post-mortem study of anatomical region differences and age-related changes. J. Trace Elem. Med. Biol. 2014, 28(1):13-17.
75. Rigdon E.E. Demonstrating the effects of unmodeled random measurement error. Struct. Equ. Model. Multidiscip. J. 1994, 1(4):375-380.
76. Rodrigue K.M., Haacke E.M., Raz N. Differential effects of age and history of hypertension on regional brain volumes and iron. NeuroImage 2011, 54(2):750-759.
77. Rogers E., Wagner A.K. Gender, sex steroids, and neuroprotection following traumatic brain injury. J. Head Trauma Rehabil. 2006, 21(3):279-281.
78. Schenck J.F. Magnetic resonance imaging of brain iron. J. Neurol. Sci. 2003, 207(1-2):99-102.
79. Schenck J.F., Zimmerman E.A. High-field magnetic resonance imaging of brain iron: birth of a biomarker?. NMR Biomed. 2004, 17(7):433-445.
80. Schweser F., Deistung A., Lehr B.W., Reichenbach J.R. Differentiation between diamagnetic and paramagnetic cerebral lesions based on magnetic susceptibility mapping. Med. Phys. 2010, 37(10):5165-5178.
81. Schweser F., Dwyer M.G., Deistung A., Reichenbach J.R., Zivadinov R. Impact of tissue atrophy on high-pass filtered MRI signal phase-based assessment in large-scale group-comparison studies: a simulation study. Front. Phys. 2013, 1(14).
82. Seeman P., Bzowej N.H., Guan H.C., Bergeron C., Becker L.E., Reynolds G.P., . . ., et al. Human brain dopamine receptors in children and aging adults. Synapse 1987, 1(5):399-404.
83. Severson J.A., Marcusson J., Winblad B., Finch C.E. Age-correlated loss of dopaminergic binding sites in human basal ganglia. J. Neurochem. 1982, 39(6):1623-1631.
84. Small B.G., McColl B.W., Allmendinger R., Pahle J., Lopez-Castejon G., Rothwell N.J., . . ., Kell D.B. Efficient discovery of anti-inflammatory small-molecule combinations using evolutionary computing. Nat. Chem. Biol. 2011, 7(12):902-908.
85. Spearman C. "General intelligence" objectively determined and measured. Am. J. Psychol. 1904, 15:201-293.
86. Stüber C., Morawski M., Schäfer A., Labadie C., Wähnert M., Leuze C., . . ., Turner R. Myelin and iron concentration in the human brain: a quantitative study of MRI contrast. NeuroImage 2014, 93(Pt 1):95-106.
87. Taylor K., Cook J., Counsell C. Heterogeneity in male to female risk for Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 2007, 78(8):905-906.
88. Tishler T.A., Raven E.P., Lu P.H., Altshuler L.L., Bartzokis G. Premenopausal hysterectomy is associated with increased brain ferritin iron. Neurobiol. Aging 2012, 33(9):1950-1958.
89. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., MacGregor R.R., . . ., Wolf A.P. Measuring age-related changes in dopamine D2 receptors with 11C-raclopride and 18F-N-methylspiroperidol. Psychiatry Res. 1996, 67(1):11-16.
90. Volkow N.D., Gur R.C., Wang G.J., Fowler J.S., Moberg P.J., Ding Y.S., . . ., Logan J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am. J. Psychiatry 1998, 155(3):344-349.
91. Wang Y., Liu T. Quantitative susceptibility mapping (QSM): decoding MRI data for a tissue magnetic biomarker. Magn. Reson. Med. 2014, 17(10):25358.
92. Wang Y., Chan G.L., Holden J.E., Dobko T., Mak E., Schulzer M., . . ., Stoessl A.J. Age-dependent decline of dopamine D1 receptors in human brain: a PET study. Synapse 1998, 30(1):56-61.
93. Ward R.J., Zucca F.A., Duyn J.H., Crichton R.R., Zecca L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 2014, 13(10):1045-1060.
94. Westlye L.T., Walhovd K.B., Dale A.M., Bjørnerud A., Due-Tønnessen P., Engvig A., . . ., Fjell A.M. Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cereb. Cortex 2010, 20(9):2055-2068.
95. Whitfield J.B., Treloar S., Zhu G., Powell L.W., Martin N.G. Relative importance of female-specific and non-female-specific effects on variation in iron stores between women. Br. J. Haematol. 2003, 120(5):860-866.
96. Xu X., Wang Q., Zhang M. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. NeuroImage 2008, 40(1):35-42.
97. Yang D., Haines C.J., Pan P., Zhang Q., Sun Y., Hong S., . . ., Liao W. Menopausal symptoms in mid-life women in southern China. Climacteric 2008, 11(4):329-3.
98. Zecca L., Stroppolo A., Gatti A., Tampellini D., Toscani M., Gallorini M., . . ., Zucca F.A. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(26):9843-9848.